Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 1985; 6:518-525
© 1985 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mathey, D.
Right arrow Articles by Dodge, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mathey, D.
Right arrow Articles by Dodge, H.

Time from onset of symptoms to thrombolytic therapy: a major determinant of myocardial salvage in patients with acute transmural infarction

DG Mathey, FH Sheehan, J Schofer, and HT Dodge

To determine whether myocardial salvage after successful intracoronary or intravenous thrombolysis is time dependent, the relation between left ventricular wall motion and the time to treatment was studied in 69 patients admitted less than 3 hours after onset of acute transmural myocardial infarction (42 patients with reperfusion by intracoronary streptokinase, 27 by intravenous urokinase). A similar significant relation between the time to treatment and the severity of regional hypokinesia at follow-up was found in the intracoronary and intravenous groups. To better define this relation, particularly during the early phase of infarction, the groups were combined. In patients in whom thrombolytic treatment was initiated within 2 hours after symptom onset, wall motion at follow-up was within 2 standard deviations of the normal mean in 82% (14 of 17 patients). If treatment was started 2 to 5 hours after symptom onset, the probability of improved wall motion decreased to 46% (24 of 52 patients, p less than 0.025). The time/wall motion relation appeared to be independent of infarct location, angiographically visible collateral vessels and the presence of subtotal coronary artery occlusion. The severity of hypokinesia at follow-up study correlated with the magnitude of peak serum creatine kinase (r = -0.71), indicating that thrombolytic therapy initiated within 2 hours after the onset of symptoms improves regional left ventricular function and reduces infarct size more than later therapy does.


This article has been cited by other articles:


Home page
ChestHome page
V. Menon, R. A. Harrington, J. S. Hochman, C. P. Cannon, S. D. Goodman, R. G. Wilcox, H. J. Schunemann, and E. M. Ohman
Thrombolysis and Adjunctive Therapy in Acute Myocardial Infarction: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Chest, September 1, 2004; 126(3_suppl): 549S - 575S.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. A.R. Pluth
Invited commentary
Ann. Thorac. Surg., July 1, 2002; 74(1): 101 - 101.
[Full Text] [PDF]


Home page
HypertensionHome page
Y. Tang, M. Jackson, K. Qian, and M. I. Phillips
Hypoxia Inducible Double Plasmid System for Myocardial Ischemia Gene Therapy
Hypertension, February 1, 2002; 39(2): 695 - 698.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
E. M. Ohman, R. A. Harrington, C. P. Cannon, G. Agnelli, J. A. Cairns, and J.W. Kennedy
Intravenous Thrombolysis in Acute Myocardial Infarction
Chest, January 1, 2001; 119 (2009): 253S - 277S.
[Full Text] [PDF]


Home page
American Journal of Medical QualityHome page
P. J. Saturno, F. Felices, J. Segura, A. Vera, J. J. Rodriguez, and ARIAM Project Group
Reducing Time Delay in the Thrombolysis of Myocardial Infarction: An Internal Quality Improvement Project
American Journal of Medical Quality, May 1, 2000; 15(3): 85 - 93.
[Abstract] [PDF]


Home page
CirculationHome page
E. T. Hasche, C. Fernandes, S. B. Freedman, and R. W. Jeremy
Relation Between Ischemia Time, Infarct Size, and Left Ventricular Function in Humans
Circulation, August 15, 1995; 92(4): 710 - 719.
[Abstract] [Full Text]


Home page
NEJMHome page
The GUSTO Angiographic Investigators
The Effects of Tissue Plasminogen Activator, Streptokinase, or Both on Coronary-Artery Patency, Ventricular Function, and Survival after Acute Myocardial Infarction
N. Engl. J. Med., November 25, 1993; 329(22): 1615 - 1622.
[Abstract] [Full Text]


Home page
JAMAHome page
J. H. Gurwitz, R. J. Goldberg, and J. M. Gore
Coronary Thrombolysis for the Elderly?
JAMA, April 3, 1991; 265(13): 1720 - 1723.
[Abstract] [PDF]


Home page
JAMAHome page
S. W. Sharkey, D. D. Brunette, E. Ruiz, W. T. Hession, D. G. Wysham, I. F. Goldenberg, and M. Hodges
An Analysis of Time Delays Preceding Thrombolysis for Acute Myocardial Infarction
JAMA, December 8, 1989; 262(22): 3171 - 3174.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
W. W. Rowe, R. J. Simpson Jr, D. A. Tate, P. W. Willis IV, T. C. Nichols, J. W. Noneman, and L. S. Gettes
Nonemergent Cardiac Catheterization and Risk-Stratified Revascularization Following Thrombolytic Therapy for Acute Myocardial Infarction: A Critical Analysis of Therapy in the Community Setting
Arch Intern Med, July 1, 1989; 149(7): 1611 - 1617.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
B. PATEL, R. A. KLONER, K. PRZYKLENK, and E. BRAUNWALD
Postischemic Myocardial "Stunning": A Clinically Relevant Phenomenon
Ann Intern Med, April 1, 1988; 108(4): 626 - 628.
[Abstract] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement